Loading...
Please wait, while we are loading the content...
Cholecystokinin antagonist lorglumide reverses chronic haloperidol-induced effects on dopamine neurons
| Content Provider | Semantic Scholar |
|---|---|
| Author | Jiang, Lian Hai Richard, J. Kasser Rex, Y. Wang |
| Copyright Year | 1988 |
| Abstract | Intravenous administration of the cholecystokinin (CCK) antagonist lorglumide (LORG) reversed chronic haloperidol (CHAL)-induced depolarization inactivation (DI) of dopamine (DA) cells in both the A9 and A10 areas. Moreover, microinjection of LORG, but not naloxone, directly into the medial nucleus accumbens (mNAc) dose-dependently reversed CHAL-induced effect. LORG injected into other brain regions was without effect. These results suggest that CCK receptors in the mNAc form an important link for maintaining CHAL-induced DI of DA cells and that CCK is involved in the therapeutic action of antipsychotic drugs. |
| Starting Page | 165 |
| Ending Page | 168 |
| Page Count | 4 |
| File Format | PDF HTM / HTML |
| DOI | 10.1016/0006-8993(88)90330-7 |
| PubMed reference number | 3208120 |
| Journal | Medline |
| Volume Number | 473 |
| Alternate Webpage(s) | https://api.elsevier.com/content/article/pii/0006899388903307 |
| Alternate Webpage(s) | https://www.sciencedirect.com/science/article/pii/0006899388903307?dgcid=api_sd_search-api-endpoint |
| Alternate Webpage(s) | https://doi.org/10.1016/0006-8993%2888%2990330-7 |
| Journal | Brain Research |
| Language | English |
| Access Restriction | Open |
| Content Type | Text |
| Resource Type | Article |